Table 1.
Baseline characteristics of enrolled participants at baseline (n = 385)
| Characteristic | N |
|---|---|
| Age (years), median (IQR) | 11 (9,10,11,12,13) |
| Female | 199 (52%) |
| Median (IQR), CD4 cells/mm3 | 375 (215–599) |
| CD4< 350 cells/mm3 | 177 (46%) |
| CD4 350–500 cells/mm3 | 74 (19%) |
| CD4> 500 cells/mm3 | 131 (34%) |
| WHO Stage 3 or 4 | |
| Mode of HIV acquisition | 155 (40%) |
| Mother‐to‐child | 369 (96%) |
| Horizontal | 13 (3%) |
| Unknown | 3 (1%) |
| Orphanhood | 157 (41%) |
| Both parents alive | 77 (20%) |
| Maternal Orphan/Father Alive | 71 (18%) |
| Paternal Orphan/Mother Alive | 58 (15%) |
| Double Orphan | 22 (6%) |
| Unknown status of either parent | |
| Biological parent as the current caregiver | 220 (57%) |
| Started ART within 4 weeks of enrolment | 206 (54%) |
| Started on ART over 18‐month follow up | 296 (77%) |
| Median days on ART for those who initiated (IQR) | 485 (359–495) |